Navigation Links
Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
Date:9/26/2007

Local Quality Improvement Organization is part of national effort to

improve health of Medicare beneficiaries

HANOVER, Md., Sept. 26 /PRNewswire-USNewswire/ -- Quality Improvement Organizations (QIOs) across the country are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries. Delmarva Foundation, Medicare's QIO for Maryland and the District of Columbia, implemented a program aimed at helping Medicare beneficiaries use prescription drugs more appropriately and effectively at their local pharmacies.

Through collaboration among Medi-CareFirst BlueCross BlueShield, University of Maryland School of Pharmacy, Howard University School of Pharmacy, and Delmarva Foundation, this program seeks to improve the safety and quality of prescription drug therapy via use of medication therapy management services (MTMS) in community-based pharmacies. MTMS focuses on improving patients' understanding of the medications they are taking and assessing patients' medications for appropriateness, as well as any potential side effects of their prescriptions.

Delmarva's collaboration was unique across the nation in that it involved local schools of pharmacy and targeted actions of community-based pharmacists.

"This initiative is win-win for providers, Medi-CareFirst, pharmacists and especially patients. Medicare beneficiaries have been able to take advantage of the knowledge and expertise of community pharmacists to help them understand their medications and to take more control of managing their own health," said Carmen Tyler Winston, Vice President, Delmarva Foundation. "In addition to providing increased access to prescription drug coverage, this program helps create a higher quality of care for Medicare beneficiaries in Maryland and the District of Columbia who are taking prescription medications."

State by state details of how other QIOs are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries are reported in a Supplement to the July/August Journal of Managed Care Pharmacy. http://amcp.org/data/jmcp/July%20B%20Supplement.pdf

Delmarva Foundation is a national, not-for-profit organization dedicated to improving healthcare quality in over 30 states. Since 1973, Delmarva has assisted in enhancing care in hospitals, nursing homes, home health agencies, medical practices and health plans. Delmarva conducts work that includes quality improvement, quality assurance, utilization review and external quality review. The company's corporate headquarters are located in Easton, Maryland with other offices in Baltimore, Maryland; Washington, DC; Columbia, South Carolina; and Tampa and Tallahassee, Florida. For more information, please visit Delmarva Foundation on the web at http://www.delmarvafoundation.org.

8SOW-MD/DC-HOSP-091307-0043

This material was prepared by Delmarva Foundation, the Medicare Quality Improvement Organization for Maryland and the District of Columbia, under contract with the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services.


'/>"/>
SOURCE Delmarva Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes Association ... Test to find out if they are at risk for developing Type 2 diabetes. ... evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... team. Ruel Williamson brings his extensive knowledge of appraisals, property values, ad valorem ... the real estate valuation industry for more than 40 years. , “Ruel is ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., ... (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products ... first of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  NuVasive, Inc. (NASDAQ: NUVA), ... spine surgery with minimally disruptive, procedurally-integrated solutions, today ... clearance of the CoRoent® Small Interbody™ System indicated ... in the cervical spine. This marks the first ... used at up to four contiguous levels. ...
(Date:3/29/2017)... , March 29, 2017 NetworkNewsWire ... ... the public safety in regulating marijuana, but economic arguments also ... creation, and reduced law enforcement costs. However, to legalize and ... provided by SinglePoint, Inc. (OTC: SING) ( SING Profile ), ...
(Date:3/29/2017)... - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical ... ended December 31, 2016 after market close on ... released later than the previous fiscal year,s results ... and balances of Apicore from the acquisition date ... date meets TSX Venture Exchange listed company requirements. ...
Breaking Medicine Technology: